Context Therapeutics Inc. Quarterly Current Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Context Therapeutics Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2024.
  • Context Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 2.01K %, a 147% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.01K +1.2K +147% Sep 30, 2024
Q2 2024 1.17K +193 +19.7% Jun 30, 2024
Q1 2024 513 -645 -55.7% Mar 31, 2024
Q4 2023 625 -818 -56.7% Dec 31, 2023
Q3 2023 814 -765 -48.5% Sep 30, 2023
Q2 2023 981 -202 -17.1% Jun 30, 2023
Q1 2023 1.16K Mar 31, 2023
Q4 2022 1.44K Dec 31, 2022
Q3 2022 1.58K Sep 30, 2022
Q2 2022 1.18K Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.